RESEARCH ARTICLE
Impaired Myocardial Bioenergetics in HFpEF and the Role of Antioxidants
John B. Hiebert, Qiuhua Shen, Amanda Thimmesch*, Janet Pierce
Article Information
Identifiers and Pagination:
Year: 2016Volume: 10
First Page: 158
Last Page: 162
Publisher ID: TOCMJ-10-158
DOI: 10.2174/1874192401610010158
Article History:
Received Date: 3/02/2016Revision Received Date: 10/6/2016
Acceptance Date: 10/6/2016
Electronic publication date: 29/07/2016
Collection year: 2016
open-access license: This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) (https://creativecommons.org/licenses/by-nc/4.0/legalcode), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
Abstract
Heart failure with preserved ejection fraction (HFpEF) is a significant cardiovascular condition for more than 50% of patients with heart failure. Currently, there is no effective treatment to decrease morbidity and mortality rates associated with HFpEF because of its pathophysiological heterogeneity. Recent evidence shows that deficiency in myocardial bioenergetics is one of the key pathophysiological factors contributing to diastolic dysfunction in HFpEF. Another known mechanism for HFpEF is an overproduction of free radicals, specifically reactive oxygen species. To reduce free radical formation, antioxidants are often used. This article is a summative review of the recent relevant literature that addresses cardiac bioenergetics, deficiency in myocardial bioenergetics, and increased reactive oxygen species associated with HFpEF and the promising potential use of antioxidants in managing this condition.
